ArticleTechnology in cancer research & treatment

Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies.

Danni Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.